RFK Jr. is supporting efforts to make peptides more widely available, despite concerns from FDA scientists about their safety. The push to increase access to peptide therapies has sparked debate and raised questions about their use and potential risks. It is unclear how the situation will be resolved, with some outlets reporting on the potential benefits and others highlighting the concerns of medical professionals.